Beam Therapeutics, Inc. (BEAM)
28.34
-1.42
(-4.77%)
USD |
NASDAQ |
Aug 24, 16:00
28.46
+0.12
(+0.42%)
After-Hours: 20:00
Beam Therapeutics Total Liabilities (Quarterly) : 318.91M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 318.91M |
| March 31, 2026 | 316.36M |
| December 31, 2025 | 242.82M |
| September 30, 2025 | 345.08M |
| June 30, 2025 | 344.34M |
| March 31, 2025 | 343.78M |
| December 31, 2024 | 370.28M |
| September 30, 2024 | 380.05M |
| June 30, 2024 | 407.17M |
| March 31, 2024 | 446.31M |
| December 31, 2023 | 478.38M |
| September 30, 2023 | 511.59M |
| June 30, 2023 | 542.24M |
| March 31, 2023 | 570.85M |
| December 31, 2022 | 608.24M |
| September 30, 2022 | 635.77M |
| Date | Value |
|---|---|
| June 30, 2022 | 618.21M |
| March 31, 2022 | 624.33M |
| December 31, 2021 | 647.72M |
| September 30, 2021 | 302.74M |
| June 30, 2021 | 344.53M |
| March 31, 2021 | 270.81M |
| December 31, 2020 | 206.12M |
| September 30, 2020 | 78.20M |
| June 30, 2020 | 69.15M |
| March 31, 2020 | 61.24M |
| December 31, 2019 | 55.15M |
| September 30, 2019 | 43.83M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 32.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Prime Medicine, Inc. | 209.23M |
| Intellia Therapeutics, Inc. | 129.46M |
| Sana Biotechnology, Inc. | 276.95M |
| Cartesian Therapeutics, Inc. | 443.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.386B |
| Shareholders Equity (Quarterly) | 1.067B |
| Debt to Equity Ratio | 0.2317 |
| Current Ratio | 14.57 |
| Net Debt Paydown Yield | -0.50% |